BioAge Labs, Inc. (NASDAQ:BIOA) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
BioAge Labs, Inc.'s stock currently trades at $18.90 with a market capitalization of $458.0M. The Healthcare company's stock moved following the disclosure.